Rakesh K Singh, PhD

Professor, Pathology & Microbiology
Courtesy Professor, Biochemistry & Molecular Biology
Courtesy Professor, Eppley Institute for Cancer Research
Member, James O Armitage Center for Hematological Malignancies Research
Member, Fred & Pamela Buffett Cancer Center

Phone402-559-9949

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Rakesh K Singh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Not started
2 Finished

Targeting CXCR2 axis in Pancreatic Cancer
Singh, R. K. & Batra, S. K.
Project: Research project
Pancreatic Tumor Micro-environment Network
Singh, R. K., Batra, S. K., Hollingsworth, T. & Johnson, K. R.
National Institutes of Health
9/26/11 → 7/31/16
Project: Research project
MOLECULAR REGULATION OF HUMAN MELANOMA METASTASIS
Singh, R. K.
National Institutes of Health
4/1/98 → 11/30/08
Project: Research project

8076 Citations
45 h-Index
134 Article
19 Review article
4 Chapter
3 Conference contribution
More
- 2 Comment/debate
- 1 Letter

Plexin-B3 regulates cellular motility, invasiveness, and metastasis in pancreatic cancer
Saxena, S., Prajapati, D. R., Goel, P., Tomar, B., Hayashi, Y., Atri, P., Rachagani, S., Grandgenett, P. M., Hollingsworth, M. A., Batra, S. K. & Singh, R. K., Feb 2021, In: Cancers. 13, 4, p. 1-19 19 p., 818.
Research output: Contribution to journal › Article › peer-review

Open Access
Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer
Ye, Z., Abdelmoaty, M. M., Ambardekar, V. V., Curran, S. M., Dyavar, S. R., Arnold, L. L., Cohen, S. M., Kumar, D., Alnouti, Y., Coulter, D. W., Singh, R. K. & Vetro, J. A., Apr 2021, In: Nanomedicine: Nanotechnology, Biology, and Medicine. 33, 102363.
Research output: Contribution to journal › Article › peer-review
Breast cancer cell–neutrophil interactions enhance neutrophil survival and pro-tumorigenic activities
Wu, L., Saxena, S., Goel, P., Prajapati, D. R., Wang, C. & Singh, R. K., Oct 2020, In: Cancers. 12, 10, p. 1-18 18 p., 2884.
Research output: Contribution to journal › Article › peer-review

Open Access
CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Awaji, M., Saxena, S., Wu, L., Prajapati, D. R., Purohit, A., Varney, M. L., Kumar, S., Rachagani, S., Ly, Q. P., Jain, M., Batra, S. K. & Singh, R. K., Jul 1 2020, In: FASEB Journal. 34, 7, p. 9405-9418 14 p.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
IL-17–CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment
Wu, L., Awaji, M., Saxena, S., Varney, M. L., Sharma, B. & Singh, R. K., Jan 2020, In: American Journal of Pathology. 190, 1, p. 222-233 12 p.
Research output: Contribution to journal › Article › peer-review
12 Scopus citations